Growth Metrics

INSMED (INSM) EBIT Margin: 2010-2014

Historic EBIT Margin for INSMED (INSM) over the last 3 years, with Jun 2014 value amounting to 3,834.62%.

  • INSMED's EBIT Margin rose 253242.00% to 3,834.62% in Q2 2014 from the same period last year, while for Jun 2014 it was 1,874.04%, marking a year-over-year decrease of 91837.00%. This contributed to the annual value of -478.39% for FY2013, which is 604038.00% down from last year.
  • Per INSMED's latest filing, its EBIT Margin stood at 3,834.62% for Q2 2014, which was up 28.53% from 2,983.33% recorded in Q1 2014.
  • Over the past 5 years, INSMED's EBIT Margin peaked at 998,300.00% during Q2 2012, and registered a low of -48.98% during Q2 2010.
  • In the last 3 years, INSMED's EBIT Margin had a median value of 3,208.00% in 2013 and averaged 153,331.07%.
  • As far as peak fluctuations go, INSMED's EBIT Margin plummeted by 99,699,780bps in 2013, and later spiked by 253,242bps in 2014.
  • Over the past 4 years, INSMED's EBIT Margin (Quarterly) stood at -31.36% in 2010, then reached 4,213.06% in 2012, then crashed by 100,506bps to 713.03% in 2013, then skyrocketed by 253,242bps to 3,834.62% in 2014.
  • Its EBIT Margin was 3,834.62% in Q2 2014, compared to 2,983.33% in Q1 2014 and 713.03% in Q4 2013.